タイトルまたは説明

Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management. It was developed by Novo Nordisk in ***2 and approved for use in the US in ***7. It is a peptide similar to the hormone glucagon-like peptide*1 (GLP*1), modified with a side chain. It can be administered by subcutaneous injection or taken orally. It is sold under the brand names Ozempic, Rybelsus, Saxenda, Mounjaro, Wegovy and others. Cas Number:**********2